Marker Therapeutics is trading up 7.53% at $0.92 during the November 9, 2026 session; no direct cause for the gain has been established. - Major U.S. indexes are rising more than 1%, which may be supporting the move. - No company announcement dated November 9 was found. The latest company-specific item found was an October 19 FDA grant announcement, which does not explain the move.